FilingReader Intelligence

Zydus gains US approval for celecoxib capsules

July 15, 2025 at 07:03 PM UTCBy FilingReader AI

Zydus Lifesciences announced final USFDA approval for celecoxib capsules in 50mg, 100mg, 200mg, and 400mg strengths. The pain and inflammation treatment had annual US sales of $122.6m as of May 2025.

The approval brings Zydus's total USFDA approvals to 428.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

BSE:ZYDUSLIFEBombay Stock Exchange

News Alerts

Get instant email alerts when Zydus Lifesciences publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →